Epigenetic Clocks Unreliable for Individuals

The event discusses the current state and limitations of epigenetic aging clocks, which are research tools used to estimate biological age based on DNA. While these clocks are highly effective for studying aging at a population level, experts Idan Shalev and Abner Apsley emphasize that they are not designed for making claims about individual health. The article explains that these clocks can provide faulty results at the individual level due to various factors, including the existence of different clock types, dynamic epigenetic changes, technical challenges in construction, lack of universal agreement on the definition of aging, and sensitivity to personal history like trauma and discrimination. The authors warn against the use of these tests by insurance companies to set premiums, which could exacerbate health disparities. Despite these limitations, epigenetic clocks are valuable for scientific research, helping to identify lifestyle habits that slow aging and test new drug therapies like Sirolimus. The overall message is that while promising, these tests are currently best suited for researchers studying populations rather than for individual consumer use.